CRISIL assigns rating to Jubilant Life Sciences’ NCDs

25 Jun 2018 Evaluate

Credit rating agency, CRISIL has assigned rating of ‘AA/Stable’ to Jubilant Life Sciences’ Non-Convertible Debentures (NCDs) worth Rs 350 crore. The rating agency has reaffirmed rating of ‘A1+’ assigned to the company’s Commercial Paper (CP) worth Rs 400 crore.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Jubilant Pharmova Share Price

837.15 -13.30 (-1.56%)
20-Mar-2026 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.80
Dr. Reddys Lab 1294.80
Cipla 1255.20
Zydus Lifesciences 888.20
Lupin 2310.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×